Clinical Trial Update: Eribulin in Advanced Solitary Fibrous Tumor [Phase 2]

View source ↗

Summary

A Phase 2 study of eribulin in advanced solitary fibrous tumor conducted by the Italian Sarcoma Group has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solitary Fibrous Tumor

Drugs mentioned

• Eribulin (Halaven) (eribulin mesylate)

Snippet

Sponsor: Italian Sarcoma Group | Conditions: Solitary Fibrous Tumor | Phase 2 | Status: COMPLETED